Amanda Foks (Div. of BioTherapeutics) has been awarded over 920.000 euro from the Dutch Heart Foundation to advance her research on age-associated B cell immunity in atherosclerotic cardiovascular disease in the coming 5 years. The Established Investigator grant will allow her to investigate the mechanism-of-action of age-associated B cells in atherosclerosis and to modulate these B cells to combat atherosclerosis.  

Link to Hartstichting article: Hartstichting Dekkerbeurzen: 3,6 miljoen euro voor onderzoek | Hartstichting

Link to Leiden University article: Over €900,000 awarded for new treatment against atherosclerosis – Leiden University